|
Market Closed -
London S.E.
11:35:01 2026-11-06 EST
|
5-day change | 1st Jan Change | ||
| 77.50 GBX | 0.00% |
|
-6.06% | -3.73% |
| 10-15 | Arecor Therapeutics Obtains Patents in Europe, US, India, for Rapid-acting Insulin | MT |
| 10-15 | Arecor Therapeutics Plc Strengthens Patent Protection For Its Proprietary AT278 Product | CI |
Evolution of the Average Target: Arecor Therapeutics plc
Evolution of the Target Price: Arecor Therapeutics plc
Changes in Analyst Recommendations: Arecor Therapeutics plc
71068f3326fa61e6c43fb7894b90e.XERX4NzFbuGL-22btI5Tvf692ClH3pal1qA7F3F47M8.CRQ6pKy_P4rlng_f3NpgycjQq3kA6-P0n8dDYhQ5q5wRc3rWjqgBs-GOIA~774a9424f0a13b3615cd00169759d7ab
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | +223.23% | ||||
| +31% | |||||
| +22.4% | |||||
| +4.89% | |||||
| +17.75% | |||||
| +12.99% | |||||
| +45.7% | |||||
| +27.37% | |||||
| +10.13% | |||||
| +23.84% | |||||
| Average | +41.93% | |||||
| Weighted average by Cap. | +21.62% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.7750GBP
Average target price
2.505GBP
Spread / Average Target
+223.23%
High Price Target
2.510GBP
Spread / Highest target
+223.87%
Low Price Target
2.500GBP
Spread / Lowest Target
+222.58%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- AREC Stock
- Consensus Arecor Therapeutics plc
Select your edition
All financial news and data tailored to specific country editions
